Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF

Boehringer Ingelheim has received Japan’s MHLW approval for Jascayd (nerandomilast) to treat adults with IPF and PPF.

Raccontata dapharmaceutical-technology.com